TrialDiabetes, obesity & metabolism2022

Efficacy and safety of oral semaglutide by baseline age in Japanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 Japan trials.

Yuichiro Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.